Pharmaceutical

LakeShore commences BLA submission to DRAP for rabies vaccine

LakeShore Biopharma has commenced the submission of its biologics license application (BLA) to the Drug Regulatory Authority of Pakistan (DRAP) seeking conditional approval for its PIKA Rabies Vaccine for post-exposure prophylaxis (PEP).

Nov 9, 2024 - 06:00
LakeShore commences BLA submission to DRAP for rabies vaccine
LakeShore Biopharma has commenced the submission of its biologics license application (BLA) to the Drug Regulatory Authority of Pakistan (DRAP) seeking conditional approval for its PIKA Rabies Vaccine for post-exposure prophylaxis (PEP).
Read the original article

Tags:

Previous Article

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets

Next Article

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vertex secures CHMP nod for Casgevy approval in Europe

Vertex secures CHMP nod for Casgevy approval in Europe

Dec 18, 2023

‘We went from almost no lockdowns to daily lockdowns’: The mental health crisis inside California women’s prisons

‘We went from almost no lockdowns to daily lockdowns’: ...

Apr 29, 2023

House passes site-neutral policy, transparency, PBM reform package

House passes site-neutral policy, transparency, PBM ref...

Dec 11, 2023